Bioinvent International AB

Suède


 
Quantité totale PI 84
Rang # Quantité totale PI 15 791
Note d'activité PI 2,5/5.0    44
Rang # Activité PI 16 788
Symbole boursier
ISIN SE0015244520
Capitalisation 2.7B  (SEK)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

20 5
12 5
38 1
3
 
Dernier brevet 2024 - Novel combinations of antibodies...
Premier brevet 1987 - Method for the removal of undesi...
Dernière marque 2024 - Y
Première marque 1999 - BIOINVENT

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 P/S Chemicals for use in industry and science; biological preparations for use in industry and scienc...
P/S Chemicals for use in industry and science; biological preparations for use in industry and scien...
2023 P/S Scientific research and development; pharmaceutical product development; consultancy pertaining t...
Invention Methods of isolating anti-ligands. The present invention relates to improved methods of isolating...
Invention Combination of a fcyrllb- and a tumor antibody for use in the treatment of an fcyriib-negative ca...
2022 Invention Novel combinations of antibodies and uses thereof. The present invention generally relates to a ...
Invention Novel combinations of antibodies and uses thereof. The present invention generally relates to a c...
Invention Novel antibodies and combined use of a treg depleting antibody and an immunostimulatory antibody....
Invention Novel combinations of antibodies and uses thereof. The present invention generally relates to an...
Invention Novel combinations of antibodies and uses thereof. The present disclosure generally relates to an...
2021 Invention Improving antibody tolerability associated with intravenous administration. The present inventio...
Invention Model for prediction of tolerability issues in connection with intravenous administration of ther...
Invention Improving antibody tolerability associated with intravenous administration. The present invention...
Invention Improving antibody tolerabilty associated with intravenous administration. Also described herein ...
P/S Chemical preparations, namely, antibodies and antibody genes stored within phages to be used in s...
Invention Lilrb3 antibody molecules and uses thereof. Described are anti-LILRB3 antibody molecules, such a...
Invention Lilrb3 antibody molecules and uses thereof. Described are anti-LILRB3 antibody molecules, such as...
2020 Invention Tetravalent antibody molecules. 222 fragments.
Invention Combination of anti-fgfr4-antibody and bile acid sequestrant. The present invention relates to th...
Invention Antibody combinations for treatment of cancer in specific patients. Described is the combined us...
Invention Antibody combinations for treatment of cancer in specific patients. Described is the combined use...
2019 Invention Novel agonistic anti tnfr2 antibody molecules. Described are novel antagonistic antibody molecul...
Invention Agonistic anti tnfr2 antibody molecules. Described are novel antibody molecules that specifically...
Invention Novel agonistic antibody molecules. Described are novel antibody molecules that specifically bind...
Invention Novel agonistic anti tnfr2 antibody molecules. Described are novel antibody molecules that specif...
Invention Novel antagonistic anti tnfr2 antibody molecules. Described are novel antagonistic antibody molec...
Invention Novel antibodies and nucleotide sequences, and uses thereof. Described are novel anti-CTLA-4 ant...
Invention Anti-ctla-4 antibodies and their use in depleting ctla-4-positive cells. Described are novel anti...
Invention Novel antibodies and nucleotide sequences, and uses thereof. Described are novel anti-CTLA-4 anti...
Invention Novel combination and use of antibodies. Described is the use of a first antibody molecule that s...
2018 Invention Novel combination and use of antibodies. Described is the use of a first antibody molecule that ...
2017 Invention Use of antibodies against icam-1 in combination with an anti cancer drug in the treatment of pati...
Invention Combination of human anti-fgfr4 antibody and sorafenib. The present invention relates to the medi...
2016 Invention Method for screening anti-ligand libraries for identifying anti-ligands specific for differential...
Invention Use of antibodies against icam-1 in the treatment of patients with relapsed cancer. There is pro...
2015 Invention Human anti-fgfr4 antibody. The present invention relates to novel antibodies against the FGF rece...
Invention Medicaments, uses and methods. Description of a composition comprising an antibody molecule and ...
Invention Medicaments, uses and methods. Description of a composition comprising an antibody molecule and a...
2014 Invention Biological materials and uses thereof. The invention provides binding molecules, including antibo...
2012 Invention Anti-icam-1 antibodies to treat multiple-myeloma related disorders. The invention relates to the...
Invention Screening methods and uses thereof. The present invention relates to improved screening methods a...
2008 P/S Chemicals and chemical products, namely, proteins for biotechnological purposes; chemical product...
2004 P/S Scientific research and development services; drug discovery services; screening genes; identifyi...
2001 P/S [ Chemicals for scientific, laboratory or medical research; chemicals for use in the manufacture ...
P/S Chemicals for analytical, diagnostic and immunological purposes and laboratory use; chemicals for...
2000 P/S proteins for scientific and research use; [ chemical preparations for use in protein analysis; ] ...
1999 P/S Chemical preparations for analytical and diagnostic purposes and laboratory use; chemical prepara...